QSAR-Derived Choline Kinase Inhibitors: How Rational can Antiproliferative Drug Design Be?

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|10|13|1095-1112

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.10, Iss.13, 2003-07, pp. : 1095-1112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

(Q)SAR Studies to Design New Human Choline Kinase Inhibitors as Antiproliferative Drugs

By  

Current Medicinal Chemistry, Vol. 13, Iss. 11, 2006-05 ,pp. : 1231-1248

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR as a Tool for the Development of Potent Antiproliferative Agents by Inhibition of Choline Kinase

By  

Current Computer - Aided Drug Design, Vol. 3, Iss. 4, 2007-12 ,pp. : 297-313

Bentham Science Publishers

Access to resources Recommend Favorite

A QSAR Analysis of 2-phenoxy-N-substituted Acetamide Analogues as Hypoxia-Inducible Factor-1(HIF-1) Inhibitors: A Rational Approach to Anticancer Drug Design

By  

Medicinal Chemistry, Vol. 8, Iss. 4, 2012-07 ,pp. : 599-614

Bentham Science Publishers

Access to resources Recommend Favorite

Rational Drug Design of DNA Oligonucleotides as HIV Inhibitors

By  

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 2, 2001-08 ,pp. : 79-90

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in Rational Drug Design of Neuraminidase Inhibitors

By  

Current Medicinal Chemistry, Vol. 14, Iss. 27, 2007-11 ,pp. : 2872-2891

Bentham Science Publishers

Access to resources Recommend Favorite